PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 175 filers reported holding PRECIGEN INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $96 | +74.5% | 67,874 | +29.6% | 0.00% | 0.0% |
| Q1 2023 | $55 | +1.9% | 52,354 | +48.2% | 0.00% | 0.0% |
| Q4 2022 | $54 | -100.0% | 35,326 | -41.1% | 0.00% | -50.0% |
| Q3 2022 | $127,000 | +44.3% | 59,959 | -8.4% | 0.00% | +100.0% |
| Q2 2022 | $88,000 | -53.7% | 65,489 | -27.1% | 0.00% | 0.0% |
| Q1 2022 | $190,000 | +102.1% | 89,822 | +252.9% | 0.00% | 0.0% |
| Q4 2021 | $94,000 | -72.2% | 25,450 | -62.4% | 0.00% | -50.0% |
| Q3 2021 | $338,000 | +297.6% | 67,769 | +418.5% | 0.00% | – |
| Q2 2021 | $85,000 | -43.7% | 13,070 | -40.3% | 0.00% | -100.0% |
| Q1 2021 | $151,000 | -18.8% | 21,880 | +19.9% | 0.00% | 0.0% |
| Q4 2020 | $186,000 | +86.0% | 18,256 | -36.3% | 0.00% | 0.0% |
| Q3 2020 | $100,000 | -45.4% | 28,657 | -21.9% | 0.00% | -50.0% |
| Q2 2020 | $183,000 | +10.2% | 36,692 | -24.8% | 0.00% | 0.0% |
| Q1 2020 | $166,000 | – | 48,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |